About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT03705260

Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients

The goal of the Twine / University of Michigan Diabetes Quality Improvement Initiative is to improve diabetes care quality using real time feedback with continuous glucose monitoring (CGM) and dietary...

Lead sponsor: University of Michigan•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Michigan

Collaborators

Twine Clinical Consulting

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Michigan Medicine patient treated by a physician in the Family Medicine Department at the Chelsea Health Center
•Diagnosis of T2D as recorded in the patient's problem list or as documented by medication list and lab results
•HbA1C \>8 for the high-risk sub-cohort

Exclusion Criteria

•Individuals for whom tight control (ie A1C \< 8) is not safe or recommended, including but not limited to older frail individuals at high-risk of hypoglycemia and falls or those with a life expectancy of less than 6 months due to a comorbid condition
•Individuals with cognitive or psychological diagnoses that might make CGM or low carbohydrate dieting risky, such as patients with eating disorders, uncontrolled psychotic - mental illness or those patients with dementia
•Women who are pregnant or breast feeding
•Individuals who had previous bariatric surgery

Related studies

RECRUITINGPhase 3

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus

Effectiveness of and Implementation Strategies for 'Disfrutando'.

NCT07023406 · Type 2 Diabetes Mellitus (T2DM)

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

NCT06821399 · Diabetes, Diabetic Retinopathy, and more

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 4, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment64

Start dateNov 2018

Last updatedFeb 4, 2021

Condition

Type 2 Diabetes Mellitus

Locations shown

Chelsea Health Center

Chelsea, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 4, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions